Your search for Warfarin returned 101 results

The researchers assessed the relative risk for influenza and ILI on the basis of body mass index and determined seroconversion and seroprotection rates using pre-vaccination and 26-35 day post-vaccination serum samples.

Bristol-Myers Squibb and Pfizer announced results from a six month Phase 3 AMPLIFY trial in patients with acute venous thromboembolism who received Eliquis (apixaban) or the current standard of care, parenteral enoxaparin treatment overlapped by warfarin therapy.

In 2017, a Work Group was assembled to conduct a systematic review of 3HP regimen studies published between January 2006 to June 2017, specifically looking at outcomes in children, individuals with HIV/AIDS, and those who self-administered treatment.

A study published in JAMA reports that anticoagulants, antibiotics, diabetes drugs, and opioids are the most common drug classes related to emergency department visits for adverse drug events in the country.

Janssen and Bayer announced the results from their real-world study XALIA, showing that the rates of major bleeding and recurrent blood clots for Xarelto (rivaroxaban) in routine clinical practice were generally consistent with Phase 3 data in patients with deep vein thrombosis (DVT), with shorter hospital stays than standard anticoagulation.

After a review of the scientific evidence for the most common ingredients found in over-the-counter dietary supplements to improve male sexual health, researchers from Wake Forest Baptist Medical Center concluded they “do not routinely recommended these products.”

Concomitant use of dabigatran with verapamil or diltiazem was found to be associated with an increased risk of bleeding in patients with normal kidney function, according to the findings of a recently published retrospective cohort study.

To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.

The FDA announced its preliminary determination that partially hydrogenated oils (PHOs) are not “generally recognized as safe” for use in food.

New research presented at the American Heart Association’s Scientific Session 2014 shows that high trans fat consumption is associated with worse memory among working-age men.